COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.BioSig Technologies, Inc. • September 12th, 2023 • Electromedical & electrotherapeutic apparatus • New York
Company FiledSeptember 12th, 2023 Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Laidlaw & Company (UK) Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 12, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to 67,565 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between Laidlaw & Company (UK) Ltd. And the Company, dated as of July 26, 2023.
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.BioSig Technologies, Inc. • May 22nd, 2023 • Electromedical & electrotherapeutic apparatus • New York
Company FiledMay 22nd, 2023 Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Laidlaw & Company (UK) Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 22, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to 62,698 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between Laidlaw & Company (UK) Ltd. And the Company, dated as of October 11, 2022.
COMMON STOCK PURCHASE WARRANTSoliton, Inc. • June 18th, 2019 • Surgical & medical instruments & apparatus
Company FiledJune 18th, 2019 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the [limitations on exercise and the]1 conditions hereinafter set forth, at any time on or after June 19, 2019 (the “Initial Exercise Date”) and on or prior to the five-year anniversary of the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Soliton, Inc., a Delaware corporation (the “Company”), up to ______shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).